Advertisement

Topics

Corvus Aims To Master Adenosine Mechanisms For PD-1/L1 Failures

10:37 EDT 2 Aug 2017 | SCRIP

Emerging Company Profile: CEO Richard Miller, who co-founded Idec and Pharmacyclics, explains Corvus's approach of building a pipeline around an...

      

Related Stories

 

Original Article: Corvus Aims To Master Adenosine Mechanisms For PD-1/L1 Failures

NEXT ARTICLE

More From BioPortfolio on "Corvus Aims To Master Adenosine Mechanisms For PD-1/L1 Failures"

Quick Search
Advertisement